Look out for the iron gap

July 2, 2014

A newly published article on pigprogress.net by Anne Mette Strunz Hanl, DVM, Ø-Vet A/S, Denmark talks about modern swine production facilities, with high production figures, where anaemia has become an issue once more.

The article focuses on the increased productivity in modern swine production and a potential iron gap as a result of that.

Well-known Prof Robert Friendship, Ontario Veterinary College, University of Guelph, Canada is quoted in the article for saying that there are several factors that are responsible for the increased iron deficiency-induced anaemia:

  1. Increased litter sizes resulting in lower iron stores at birth
  2. Increased spread in birth weights and growth rates as a direct consequence
  3. Accelerated growth rates for piglets born with above-average birth weights result in increased risk of depletion of available iron stores
  4. Low levels of iron in the sow's milk are diminished to even lower levels with the increased litter sizes.

The article also deals with the subject "Turning risk into and advantage" and "Detecting and treating anaemia.

Read the full article on pigprogress.net - Click here

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.